ICH S9 guideline

Oncology

Successfully navigating the process for drugs with a higher risk-benefit ratio requires a tailored non-clinical programme design.

News

A study has found evidence that 11 cancers are becoming more common among young people in England, and points to a main driving factor.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.